Skin and Tissue Diseases

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Skin and Tissue Diseases

Top of Directory » All Categories » by Illness » Skin and Tissue Diseases



  • OTIS Autoimmune Diseases in Pregnancy Project

    Conditions:   Ankylosing Spondylitis;   Psoriatic Arthritis;   Psoriasis;   Rheumatoid Arthritis
    Intervention:  
    Sponsors:   University of California, San Diego;   Organization of Teratology Information Specialists (OTIS);   Amgen
    Recruiting - verified November 2009
  • Study Evaluating Multiple Ascending Doses of ATN-103 in Japanese Subjects With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: ATN-103 10 mg q4wks;   Biological: ATN-103 30 mg q4wks;   Biological: ATN-103 80 mg q4wks;   Biological: ATN-103 10 mg q8wks;   Biological: ATN-103 80 mg q8wks
    Sponsor:   Wyeth
    Recruiting - verified November 2009
  • Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

    Conditions:   Arthritis;   Arthritis, Rheumatoid;   Autoimmune Diseases
    Interventions:   Drug: golimumab;   Drug: golimumab or placebo;   Drug: golimumab or placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009
  • Vaccination Against Influenza H1N1 in Rheumatic Diseases

    Conditions:   Influenza;   Rheumatic Diseases
    Interventions:   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine);   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine);   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Not yet recruiting - verified November 2009
  • Merkel Positron Emission Tomography (PET) Protocol

    Condition:   Stage I or II Merkel Cell Cancer of the Skin
    Interventions:   Drug: Carboplatin;   Drug: Etoposide;   Radiation: Radiotherapy
    Sponsor:   Trans-Tasman Radiation Oncology Group (TROG)
    Not yet recruiting - verified November 2009
  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009
  • Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

    Conditions:   Bladder Cancer;   Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: docetaxel;   Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Active, not recruiting - verified November 2009
  • Influenza Vaccination in Patients With Scleroderma

    Condition:   Influenza Vaccine in Scleroderma
    Intervention:   Biological: Influenza vaccine
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Not yet recruiting - verified August 2009
  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

    Condition:   Non-curative Resectable Bile Duct Carcinoma
    Intervention:   Drug: Temoporfin
    Sponsors:   University of Salzburg;   Biolitec Pharma ltd., United Drug House, Magna Drive,Dublin 24,Irland
    Recruiting - verified November 2009
  • Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast Cancer

    Condition:   Breast Cancer
    Intervention:   Other: Phase II - Preoperative Radiation followed by Lumpectomy.
    Sponsor:   University of Maryland
    Recruiting - verified November 2009
  • Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

    Condition:   Staphylococcus Aureus
    Interventions:   Biological: Monovalent rAT;   Biological: Monovalent rLukS-PV;   Biological: Bivalent rLukS-PV / rAT;   Biological: Placebo with adjuvant;   Biological: Placebo
    Sponsors:   Uniformed Services University of the Health Sciences;   Nabi Biopharmaceuticals
    Recruiting - verified November 2009
  • Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

    Condition:   Mild to Moderate Psoriasis
    Intervention:   Drug: Psirelax
    Sponsor:   Etwal Ltd.
    Completed - verified October 2009
  • A Clinical Investigation to Evaluate Negative Pressure Wound Therapy (NPWT) System in the Treatment of Diabetic Foot Ulcers (DFUs) Including Post Amputation Wounds Associated With Diabetes

    Conditions:   Diabetes;   Foot Ulcers
    Intervention:   Procedure: AvanceTM NPWT System
    Sponsor:   Molnlycke Health Care AB
    Not yet recruiting - verified November 2009
  • Postoperative Pain After Volar Plating for Distal Radius Fractures

    Condition:   Distal Radius Fractures
    Intervention:   Procedure: periarticular anesthetics injection
    Sponsors:   Seoul National University Hospital;   Seoul National University Bundang Hospital
    Completed - verified November 2009
  • Study Evaluating Single Dose of ILV-095 in Psoriasis Subjects

    Condition:   Plaque Psoriasis
    Interventions:   Drug: ILV-095 300 mg in a 4 to 1 ratio;   Drug: ILV-095 placebo 300 mg in a 4 to 1 ratio
    Sponsor:   Wyeth
    Not yet recruiting - verified November 2009
  • Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

    Conditions:   Breast Cancer;   Lung Cancer;   Colon Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Kidney Cancer;   Sarcoma;   Hepatocellular Cancer
    Interventions:   Drug: Pazopanib;   Drug: Pazopanib;   Drug: Ixabepilone;   Drug: Ixabepilone;   Drug: Ixabepilone
    Sponsors:   Masonic Cancer Center, University of Minnesota;   GlaxoSmithKline;   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100/MART

    Condition:   Melanoma
    Interventions:   Drug: CP 870,893;   Biological: Peptides;   Biological: Oncovir poly IC:LC
    Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Cancer Institute (NCI);   Oncovir, Inc.
    Recruiting - verified November 2009
  • Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Genetic: cytogenetic analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Other: mass spectrometry
    Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI)
    Not yet recruiting - verified October 2009
  • Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: ritonavir;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
    Sponsors:   Masonic Cancer Center, University of Minnesota;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009
  • Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Procedure: adjuvant therapy;   Radiation: accelerated partial breast irradiation;   Radiation: intracavitary balloon brachytherapy
    Sponsors:   Arthur G. James Cancer Hospital & Richard J. Solove Research Institute;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009
  • Fractional Photothermolysis for the Treatment of Burn Scars

    Condition:   Scar
    Interventions:   Procedure: Fractional laser treatment;   Procedure: Standard scar management
    Sponsors:   Clinica las Condes, Chile;   Corporacion de ayuda al niño quemado (COANIQUEM);   Solta Medical
    Not yet recruiting - verified October 2009
  • Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

    Conditions:   Intraocular Melanoma;   Melanoma (Skin)
    Interventions:   Drug: sunitinib malate;   Drug: temozolomide
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting - verified October 2009
  • Effects of Tamoxifen in Women With Benign Breast Disease Not Having Any Risks of Developing Breast Cancer

    Conditions:   Benign Breast Disease;   Fibrocystic Disease of Breast;   Fibroadenoma;   Mastalgia
    Interventions:   Drug: Tamoxifen;   Drug: Evening Primrose Oil
    Sponsor:   Medical College and Hospital Kolkata
    Completed - verified November 2009
  • Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma

    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
    Intervention:   Drug: Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan
    Sponsors:   Duke University;   Genentech;   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Study of Tissue and Blood Samples in Women With Locally Advanced or Metastatic Breast Cancer Undergoing Chemotherapy Before Surgery

    Condition:   Breast Cancer
    Interventions:   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Procedure: biopsy
    Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified October 2009
  • SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)

    Condition:   Breast Cancer
    Intervention:   Radiation: Imaging investigations (with radiation)
    Sponsor:   Royal Marsden NHS Foundation Trust
    Recruiting - verified October 2009
  • Acupuncture for the Treatment of Chronic Lymphedema

    Conditions:   Breast Cancer;   Lymphedema
    Intervention:   Procedure: Acupuncture
    Sponsor:   Memorial Sloan-Kettering Cancer Center
    Recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials